Organon & Co
OGN
$13.77+0.00%
End of day · as of Oct 14, 2026, 8:30 AM ET
Mkt cap
$2.52B
EV/Sales
1.70
P/E ratio
N/A
FY2025 Revenue
$6.22B
EPS (H1 2026)
$0.95
Gross Margin (FY2025)
53.30%
Profit Margin (FY2025)
3.01%
Beta
0.55
Div yield
0.83%
Sector
Healthcare
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported OGN revenue for 2025-12-31 was $6.22B. Net income was $187.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OGN currently screens at market cap $2.52B.
Use this OGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full OGN income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Organon & Co (OGN) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Organon & Co (OGN) revenue for Dec 31, 2025 was $6.22B. Net income was $187.0M. Statements: https://lician.com/financials/ogn
Organon & Co (OGN) market capitalization is $2.52B on the latest cached snapshot.
Organon & Co (OGN) cached previous close $13.77; day range $13.77 – $13.78; volume 2,886,258. Session quote: https://lician.com/quote/ogn
Organon & Co (OGN) latest cached earnings event is "OGN earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached OGN filing is 8-K · Jul 31, 2026. Filings: https://lician.com/sec/ogn